Medexus Pharmaceuticals (MDP) Earnings Date, Estimates & Call Transcripts → This company has increased its dividend every year for 54 years (From DTI) (Ad) Free MDP Stock Alerts C$1.51 -0.03 (-1.95%) (As of 04/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarnings Earnings SummaryUpcoming Earnings DateJun. 19EstimatedActual EPS (Feb. 7) -C$0.03 Missed By -C$0.13 Consensus EPS (Feb. 7) C$0.10 Get Medexus Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for MDP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueMDP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MDP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Tips4TradersUncover this 2024 Hidden GemExclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.[Click here to subscribe] and elevate your trading today. Medexus Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242C($0.08)C($0.05)C($0.07)Q2 20242C($0.04)C$0.05C$0.01Q3 20242C$0.04C$0.12C$0.08Q4 20242C$0.04C$0.07C$0.06FY 20248C($0.04)C$0.19C$0.08Q1 20251C$0.03C$0.03C$0.03Q2 20251C$0.04C$0.04C$0.04Q3 20251C$0.08C$0.08C$0.08Q4 20251C$0.12C$0.12C$0.12FY 20254C$0.27C$0.27C$0.27MDP Earnings Date and InformationMedexus Pharmaceuticals last posted its quarterly earnings data on February 7th, 2024. The reported C($0.03) EPS for the quarter, missing the consensus estimate of C$0.10 by C$0.13. The company had revenue of C$34.33 million for the quarter, compared to analysts' expectations of C$42.33 million. Medexus Pharmaceuticals has generated C$0.40 earnings per share over the last year (C$0.40 diluted earnings per share) and currently has a price-to-earnings ratio of 3.8. Medexus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 19th, 2024 based off prior year's report dates.Read More Medexus Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/19/2024Estimated)------- 2/7/2024Q3 2024C$0.10C($0.03)C($0.13)C($0.03)C$42.33 millionC$34.33 million11/8/2023Q2 2024-C($0.08)C($0.08)C($0.09)-C$40.69 million8/9/2023Q1 2024C($0.03)C$0.04+C$0.07C$0.04C$39.98 millionC$42.39 million6/21/2023Q4 2023C($0.07)C$0.41+C$0.48C$0.36C$38.17 millionC$38.72 million2/8/2023Q3 2023C($0.09)C($0.10)C($0.01)C($0.10)C$37.16 millionC$39.01 million11/8/2022Q2 2023C($0.18)C($0.19)C($0.01)C($0.20)C$30.00 millionC$36.13 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q1 2023C($0.17)C($0.23)C($0.06)C($0.37)C$26.04 millionC$29.42 million6/22/2022Q4 2022C($0.40)C($0.29)+C$0.11C($0.24)C$21.69 millionC$25.67 million2/9/2022Q3 2022C($0.32)C($0.21)+C$0.11C($0.33)C$23.32 millionC$26.82 million11/10/2021Q2 2022C($0.39)C($0.39)-C($1.43)C$23.99 millionC$22.54 million8/16/2021Q1 2022C($0.29)C($0.63)C($0.34)C($0.84)C$24.61 millionC$21.22 million6/16/2021Q4 2021C$0.09C($0.41)C($0.50)C($0.02)C$27.60 millionC$22.34 million Medexus Pharmaceuticals Earnings - Frequently Asked Questions When is Medexus Pharmaceuticals's earnings date? Medexus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 19th, 2024 based off last year's report dates. Learn more on MDP's earnings history. Did Medexus Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Medexus Pharmaceuticals (TSE:MDP) missed the analysts' consensus estimate of C$0.10 by C$0.13 with a reported earnings per share (EPS) of C($0.03). Learn more on analysts' earnings estimate vs. MDP's actual earnings. How much revenue does Medexus Pharmaceuticals generate each year? Medexus Pharmaceuticals (TSE:MDP) has a recorded annual revenue of C$115.72 million. How much profit does Medexus Pharmaceuticals generate each year? Medexus Pharmaceuticals (TSE:MDP) has a recorded net income of C$5.88 million. MDP has generated C$0.40 earnings per share over the last four quarters. What is Medexus Pharmaceuticals's price-to-earnings ratio? Medexus Pharmaceuticals (TSE:MDP) has a trailing price-to-earnings ratio of 3.78 and a forward price-to-earnings ratio of 13.89. More Earnings Resources from MarketBeat Related Companies: DB Earnings Date VPH Earnings Date MPH Earnings Date RX Earnings Date HBP Earnings Date TLT Earnings Date AKU Earnings Date IBT Earnings Date APS Earnings Date COV Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings call This page (TSE:MDP) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.